It is time for a new comprehensive medication review quality measure

Medication therapy management (MTM) services include comprehensive medication reviews (CMRs), which have been com-pleted with millions of patients since their inception in the United States. The current MTM quality measure focuses on whether CMRs were completed (ie, the CMR comple-tion rate). However, this process measure does not assess quality of care, or patient -reported or other outcomes of CMRs, and, therefore, does not reward MTM provid-ers for improving health outcomes. In this viewpoint article, we present 3 reasons that shape our argument for new MTM quality measures and offer recommendations on next steps to achieve this.